
|Articles|January 24, 2008
Antihistamine's new label covers both indoor and outdoor allergies
In a new labeling change, Schering-Plough's Claritin can now treat both indoor and outdoor allergies
Advertisement
Schering-Plough reported that FDA has approved a labeling change for its over-the-counter Claritin (loratadine). The new label now states that the non-drowsy OTC drug relieves allergy symptoms caused by both indoor (or perennial) and outdoor (or seasonal) allergies. Indoor allergens include mold, dust mites, and pet dander, while outdoor allergens cover grass and pollen.
To see more Daily News articles,
To go to the Drug Topics homepage,
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Targeted Coordination Is Crucial in Boosting Pneumococcal Vaccine Coverage
2
CoronaVac Improves Outcomes of COVID-19 for Patients With Schizophrenia
3
From Policy to Practice: Elevating Pharmacy’s Role in Quality and Patient Safety
4
Reducing HIV Stigma Can Improve Patient Care, Provider Connectivity
5
















































































































